Global Veterinary Biomarkers Market Size, Share & Industry Trends Analysis Report By Animal Type, By Disease Type, By Product Type (Biomarkers, Kits & Reagents and Biomarker Readers), By Application, By Regional Outlook and Forecast, 2022 - 2028

Global Veterinary Biomarkers Market Size, Share & Industry Trends Analysis Report By Animal Type, By Disease Type, By Product Type (Biomarkers, Kits & Reagents and Biomarker Readers), By Application, By Regional Outlook and Forecast, 2022 - 2028

The Global Veterinary Biomarkers Market size is expected to reach $1.5 billion by 2028, rising at a market growth of 11.7% CAGR during the forecast period.

Biomarkers are sensors of biological processes and pathological conditions that can indicate a variety of characteristics associated with health and disease. This assessment often consists of a molecule (such as a hormone or cell surface receptor) that can be found in blood or other tissues and, in general, represents the overall health of a patient is in. For instance, the measurement of a biomarker may reveal the activity of a metabolic pathway or the amount of protein expression that may be connected to the development of a disease like diabetes, pancreatitis, or cancer, to name a few.

Clinical medicine uses biomarkers specifically for risk assessment, disease diagnosis, prognostication, therapy response monitoring, and relapse detection. Biomarkers are very essential in medical and veterinary research because they help characterize human and animal diseases. With the rising importance of human medicine, biomarkers are also of interest in veterinary medicine, where they may help not only with the early identification of disease but also with disease monitoring in patients, both during and after therapy.

Biomarkers may play the largest role in cancer medicine, much like they do in human medicine. A few biomarkers have been studied in veterinary oncology both in vitro and in vivo, particularly for canine hemangiosarcoma (HSA). Additionally, a commercial blood test for canine lymphoma (LSA) is currently available. Depending on its intended usage, a good veterinary biomarker should have specific properties and characteristics. It needs to be precise, sensitive, and particular.

The biomarker should change as per the applicable disease and be able to distinguish between patients and healthy controls. The biomarker should also be quantified in a reliable and repeatable manner. For diagnostic purposes, it is preferable to extract biomarkers from readily available animal body fluids such as blood plasma, urine, perspiration, and saliva, as well as other reachable materials like hair and excrement. The proper evaluation of clinical responses to therapy and the direction of treatment program decisions are both made possible by the identification and quantification of biomarkers.

COVID-19 Impact Analysis

The American Veterinary Medical Association claims that providing veterinary care during the pandemic has proven difficult for veterinarians in the United States. However, veterinary clinics have long been seen as a crucial part of the nation's healthcare system. Additionally, healthcare systems focused more of their resources on urgent situations, which had an impact on animal diagnostic tests. Moreover, the supply chain for meats and other dietary items generated from animals was disrupted during the pandemic. As a result, fewer food items originating from animals were consumed, which had an impact on the sector.

Market Growth Factors

Rising Incidents Of Zoonotic Diseases And Facilitation Of Research

The rising prevalence of zoonotic and foodborne diseases will affect the growth of the market. Like COVID-19, around three-quarters of novel and emerging infectious diseases in humans are zoonotic, meaning they can spread from animals to people. The leaders from G-7 countries called for "affordable and equitable access to diagnostics" as well as strengthening the 'One Health' strategy, which brings together veterinary, medical, and environmental disciplines in a collaborative effort to combat COVID-19 and future pandemics. According to estimates made before the current pandemic, zoonosis cause 2.5 billion cases of human sickness and 2.7 million fatalities annually.

Increasing Use Of Animal Aid In Pet Therapy

Pet therapy is a general phrase that covers both therapeutic animal-assisted activities and other animal-assisted pursuits. Dogs or other animals are used in the emerging field of animal-assisted therapy to support individuals in healing from or better coping with health issues like heart disease, cancer, and mental health disorders. On the other hand, animal-assisted activities serve a more broad function, such as comforting and entertaining nursing home residents. This has gained momentum after its successful impact on people suffering from PTSD.

Market Restraining Factors

Differences In Veterinarian Services Among Developed And Developing Nations

Most developing nations even lack proper human health services. In such cases, the expectation of the provision of biomarkers on animals still remains a futuristic idea. In many sections of developing countries, the issue is not how to create new, more efficient diagnostic tools, medications, or immunizations. Instead, more efficient veterinary service organizational structures are more crucial than improved diagnostic techniques. Community-based animal health workers, who reside in the livestock-keeping communities and offer the neighborhood animal’s affordable "first aid" for the efficient control of diseases, are another example of more necessary services.

Animal Type Outlook

On the basis of animal type, the market for veterinary biomarkers is bifurcated into companion animals (Dogs, Cats, and Others) and production animals. The companion animals segment acquired the highest revenue share in the veterinary biomarkers market in 2021. This is a result of both the considerable disease prevalence rates that were seen in dogs and the increased adoption rates for canines. It also decisively stated that cats outnumbered dogs as pets.

Product Type Outlook

Based on product type, the veterinary biomarkers market is segmented as biomarkers, kits & reagents and biomarker readers. The biomarkers, kits, and reagents segment recorded the maximum revenue share in the veterinary biomarkers market in 2021. This is due to the widespread availability of popular brands of biomarkers and test kits introduced by influential market participants. To comprehend the disorder's course and to offer targeted treatments that specifically target the disease's biological indicator, veterinarians choose sensitive and accurate disease diagnostic methods using biomarker test kits.

Application Outlook

On the basis of application, the market for veterinary biomarkers is classified as disease diagnostics, preclinical research, and others. The preclinical research segment witnessed a significant revenue share in the veterinary biomarkers market in 2021. This is because veterinary biomarkers and post-genomic technologies are the subjects of more and more study and development. The prospect for segment expansion is being further enhanced by the cutting-edge techniques adopted by key players in the animal health industry to identify novel biomarkers or disease indicators.

Disease Type Outlook

Based on disease type, the veterinary biomarkers market is categorized as inflammatory & infectious diseases, Turf & Landscaping, skeletal muscle diseases, tumor, and others. The tumor segment garnered a promising revenue share in the veterinary biomarkers market in 2021. Biomarkers will undoubtedly continue to develop into useful diagnostic tools, especially for conditions like cancer, but a single screening method by itself cannot and should not take the place of a thorough physical and diagnostic examination.

Regional Outlook

On the basis of region, the veterinary biomarkers market can be categorized across North America, Europe, Asia Pacific, and LAMEA. The North America procured the largest revenue share in the veterinary biomarkers market in 2021. The significant presence of key players, the adoption of various strategies developed by key companies to increase market penetration, rising research activities, rising diagnostic rates, rising animal population, and rising veterinary care costs are all factors that contribute to the region's high share.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zoetis, Inc., Merck & Co., Inc., Virbac, IDEXX Laboratories, Inc., MI:RNA Diagnostics Ltd., Mercodia AB, Antech Diagnostics, Inc. (Mars, Inc.), Avacta Animal Health Limited (Vimian Group), Life Diagnostics, Inc., and Acuvet Biotech.

Scope of the Study

Market Segments covered in the Report:

By Animal Type

  • Companion
Dogs

Cats

Others
  • Production
By Disease Type
  • Inflammatory & Infectious Diseases
  • Turf & Landscaping
  • Tumor
  • Skeletal Muscle Diseases
  • Others
By Product Type
  • Biomarkers, Kits & Reagents
  • Biomarker Readers
By Application
  • Disease Diagnostics
  • Preclinical Research
  • Others
By Geography
  • North America
US

Canada

Mexico

Rest of North America
  • Europe
Germany

UK

France

Russia

Spain

Italy

Rest of Europe
  • Asia Pacific
China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific
  • LAMEA
Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled
  • Zoetis, Inc.
  • Merck & Co., Inc.
  • Virbac
  • IDEXX Laboratories, Inc.
  • MI:RNA Diagnostics Ltd.
  • Mercodia AB
  • Antech Diagnostics, Inc. (Mars, Inc.)
  • Avacta Animal Health Limited (Vimian Group)
  • Life Diagnostics, Inc.
  • Acuvet Biotech
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Veterinary Biomarkers Market, by Animal Type
1.4.2 Global Veterinary Biomarkers Market, by Disease Type
1.4.3 Global Veterinary Biomarkers Market, by Product Type
1.4.4 Global Veterinary Biomarkers Market, by Application
1.4.5 Global Veterinary Biomarkers Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Veterinary Biomarkers Market by Animal Type
3.1 Global Companion Market by Region
3.2 Global Veterinary Biomarkers Market by Companion Animal Type
3.2.1 Global Dogs Market by Region
3.2.2 Global Cats Market by Region
3.2.3 Global Others Market by Region
3.3 Global Production Market by Region
Chapter 4. Global Veterinary Biomarkers Market by Disease Type
4.1 Global Inflammatory & Infectious Diseases Market by Region
4.2 Global Turf & Landscaping Market by Region
4.3 Global Tumor Market by Region
4.4 Global Skeletal Muscle Diseases Market by Region
4.5 Global Others Market by Region
Chapter 5. Global Veterinary Biomarkers Market by Product Type
5.1 Global Biomarkers, Kits & Reagents Market by Region
5.2 Global Biomarker Readers Market by Region
Chapter 6. Global Veterinary Biomarkers Market by Application
6.1 Global Disease Diagnostics Market by Region
6.2 Global Preclinical Research Market by Region
6.3 Global Others Market by Region
Chapter 7. Global Veterinary Biomarkers Market by Region
7.1 North America Veterinary Biomarkers Market
7.1.1 North America Veterinary Biomarkers Market by Animal Type
7.1.1.1 North America Companion Market by Country
7.1.1.2 North America Veterinary Biomarkers Market by Companion Animal Type
7.1.1.2.1 North America Dogs Market by Country
7.1.1.2.2 North America Cats Market by Country
7.1.1.2.3 North America Others Market by Country
7.1.1.3 North America Production Market by Country
7.1.2 North America Veterinary Biomarkers Market by Disease Type
7.1.2.1 North America Inflammatory & Infectious Diseases Market by Country
7.1.2.2 North America Turf & Landscaping Market by Country
7.1.2.3 North America Tumor Market by Country
7.1.2.4 North America Skeletal Muscle Diseases Market by Country
7.1.2.5 North America Others Market by Country
7.1.3 North America Veterinary Biomarkers Market by Product Type
7.1.3.1 North America Biomarkers, Kits & Reagents Market by Country
7.1.3.2 North America Biomarker Readers Market by Country
7.1.4 North America Veterinary Biomarkers Market by Application
7.1.4.1 North America Disease Diagnostics Market by Country
7.1.4.2 North America Preclinical Research Market by Country
7.1.4.3 North America Others Market by Country
7.1.5 North America Veterinary Biomarkers Market by Country
7.1.5.1 US Veterinary Biomarkers Market
7.1.5.1.1 US Veterinary Biomarkers Market by Animal Type
7.1.5.1.2 US Veterinary Biomarkers Market by Disease Type
7.1.5.1.3 US Veterinary Biomarkers Market by Product Type
7.1.5.1.4 US Veterinary Biomarkers Market by Application
7.1.5.2 Canada Veterinary Biomarkers Market
7.1.5.2.1 Canada Veterinary Biomarkers Market by Animal Type
7.1.5.2.2 Canada Veterinary Biomarkers Market by Disease Type
7.1.5.2.3 Canada Veterinary Biomarkers Market by Product Type
7.1.5.2.4 Canada Veterinary Biomarkers Market by Application
7.1.5.3 Mexico Veterinary Biomarkers Market
7.1.5.3.1 Mexico Veterinary Biomarkers Market by Animal Type
7.1.5.3.2 Mexico Veterinary Biomarkers Market by Disease Type
7.1.5.3.3 Mexico Veterinary Biomarkers Market by Product Type
7.1.5.3.4 Mexico Veterinary Biomarkers Market by Application
7.1.5.4 Rest of North America Veterinary Biomarkers Market
7.1.5.4.1 Rest of North America Veterinary Biomarkers Market by Animal Type
7.1.5.4.2 Rest of North America Veterinary Biomarkers Market by Disease Type
7.1.5.4.3 Rest of North America Veterinary Biomarkers Market by Product Type
7.1.5.4.4 Rest of North America Veterinary Biomarkers Market by Application
7.2 Europe Veterinary Biomarkers Market
7.2.1 Europe Veterinary Biomarkers Market by Animal Type
7.2.1.1 Europe Companion Market by Country
7.2.1.2 Europe Veterinary Biomarkers Market by Companion Animal Type
7.2.1.2.1 Europe Dogs Market by Country
7.2.1.2.2 Europe Cats Market by Country
7.2.1.2.3 Europe Others Market by Country
7.2.1.3 Europe Production Market by Country
7.2.2 Europe Veterinary Biomarkers Market by Disease Type
7.2.2.1 Europe Inflammatory & Infectious Diseases Market by Country
7.2.2.2 Europe Turf & Landscaping Market by Country
7.2.2.3 Europe Tumor Market by Country
7.2.2.4 Europe Skeletal Muscle Diseases Market by Country
7.2.2.5 Europe Others Market by Country
7.2.3 Europe Veterinary Biomarkers Market by Product Type
7.2.3.1 Europe Biomarkers, Kits & Reagents Market by Country
7.2.3.2 Europe Biomarker Readers Market by Country
7.2.4 Europe Veterinary Biomarkers Market by Application
7.2.4.1 Europe Disease Diagnostics Market by Country
7.2.4.2 Europe Preclinical Research Market by Country
7.2.4.3 Europe Others Market by Country
7.2.5 Europe Veterinary Biomarkers Market by Country
7.2.5.1 Germany Veterinary Biomarkers Market
7.2.5.1.1 Germany Veterinary Biomarkers Market by Animal Type
7.2.5.1.2 Germany Veterinary Biomarkers Market by Disease Type
7.2.5.1.3 Germany Veterinary Biomarkers Market by Product Type
7.2.5.1.4 Germany Veterinary Biomarkers Market by Application
7.2.5.2 UK Veterinary Biomarkers Market
7.2.5.2.1 UK Veterinary Biomarkers Market by Animal Type
7.2.5.2.2 UK Veterinary Biomarkers Market by Disease Type
7.2.5.2.3 UK Veterinary Biomarkers Market by Product Type
7.2.5.2.4 UK Veterinary Biomarkers Market by Application
7.2.5.3 France Veterinary Biomarkers Market
7.2.5.3.1 France Veterinary Biomarkers Market by Animal Type
7.2.5.3.2 France Veterinary Biomarkers Market by Disease Type
7.2.5.3.3 France Veterinary Biomarkers Market by Product Type
7.2.5.3.4 France Veterinary Biomarkers Market by Application
7.2.5.4 Russia Veterinary Biomarkers Market
7.2.5.4.1 Russia Veterinary Biomarkers Market by Animal Type
7.2.5.4.2 Russia Veterinary Biomarkers Market by Disease Type
7.2.5.4.3 Russia Veterinary Biomarkers Market by Product Type
7.2.5.4.4 Russia Veterinary Biomarkers Market by Application
7.2.5.5 Spain Veterinary Biomarkers Market
7.2.5.5.1 Spain Veterinary Biomarkers Market by Animal Type
7.2.5.5.2 Spain Veterinary Biomarkers Market by Disease Type
7.2.5.5.3 Spain Veterinary Biomarkers Market by Product Type
7.2.5.5.4 Spain Veterinary Biomarkers Market by Application
7.2.5.6 Italy Veterinary Biomarkers Market
7.2.5.6.1 Italy Veterinary Biomarkers Market by Animal Type
7.2.5.6.2 Italy Veterinary Biomarkers Market by Disease Type
7.2.5.6.3 Italy Veterinary Biomarkers Market by Product Type
7.2.5.6.4 Italy Veterinary Biomarkers Market by Application
7.2.5.7 Rest of Europe Veterinary Biomarkers Market
7.2.5.7.1 Rest of Europe Veterinary Biomarkers Market by Animal Type
7.2.5.7.2 Rest of Europe Veterinary Biomarkers Market by Disease Type
7.2.5.7.3 Rest of Europe Veterinary Biomarkers Market by Product Type
7.2.5.7.4 Rest of Europe Veterinary Biomarkers Market by Application
7.3 Asia Pacific Veterinary Biomarkers Market
7.3.1 Asia Pacific Veterinary Biomarkers Market by Animal Type
7.3.1.1 Asia Pacific Companion Market by Country
7.3.1.2 Asia Pacific Veterinary Biomarkers Market by Companion Animal Type
7.3.1.2.1 Asia Pacific Dogs Market by Country
7.3.1.2.2 Asia Pacific Cats Market by Country
7.3.1.2.3 Asia Pacific Others Market by Country
7.3.1.3 Asia Pacific Production Market by Country
7.3.2 Asia Pacific Veterinary Biomarkers Market by Disease Type
7.3.2.1 Asia Pacific Inflammatory & Infectious Diseases Market by Country
7.3.2.2 Asia Pacific Turf & Landscaping Market by Country
7.3.2.3 Asia Pacific Tumor Market by Country
7.3.2.4 Asia Pacific Skeletal Muscle Diseases Market by Country
7.3.2.5 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Veterinary Biomarkers Market by Product Type
7.3.3.1 Asia Pacific Biomarkers, Kits & Reagents Market by Country
7.3.3.2 Asia Pacific Biomarker Readers Market by Country
7.3.4 Asia Pacific Veterinary Biomarkers Market by Application
7.3.4.1 Asia Pacific Disease Diagnostics Market by Country
7.3.4.2 Asia Pacific Preclinical Research Market by Country
7.3.4.3 Asia Pacific Others Market by Country
7.3.5 Asia Pacific Veterinary Biomarkers Market by Country
7.3.5.1 China Veterinary Biomarkers Market
7.3.5.1.1 China Veterinary Biomarkers Market by Animal Type
7.3.5.1.2 China Veterinary Biomarkers Market by Disease Type
7.3.5.1.3 China Veterinary Biomarkers Market by Product Type
7.3.5.1.4 China Veterinary Biomarkers Market by Application
7.3.5.2 Japan Veterinary Biomarkers Market
7.3.5.2.1 Japan Veterinary Biomarkers Market by Animal Type
7.3.5.2.2 Japan Veterinary Biomarkers Market by Disease Type
7.3.5.2.3 Japan Veterinary Biomarkers Market by Product Type
7.3.5.2.4 Japan Veterinary Biomarkers Market by Application
7.3.5.3 India Veterinary Biomarkers Market
7.3.5.3.1 India Veterinary Biomarkers Market by Animal Type
7.3.5.3.2 India Veterinary Biomarkers Market by Disease Type
7.3.5.3.3 India Veterinary Biomarkers Market by Product Type
7.3.5.3.4 India Veterinary Biomarkers Market by Application
7.3.5.4 South Korea Veterinary Biomarkers Market
7.3.5.4.1 South Korea Veterinary Biomarkers Market by Animal Type
7.3.5.4.2 South Korea Veterinary Biomarkers Market by Disease Type
7.3.5.4.3 South Korea Veterinary Biomarkers Market by Product Type
7.3.5.4.4 South Korea Veterinary Biomarkers Market by Application
7.3.5.5 Singapore Veterinary Biomarkers Market
7.3.5.5.1 Singapore Veterinary Biomarkers Market by Animal Type
7.3.5.5.2 Singapore Veterinary Biomarkers Market by Disease Type
7.3.5.5.3 Singapore Veterinary Biomarkers Market by Product Type
7.3.5.5.4 Singapore Veterinary Biomarkers Market by Application
7.3.5.6 Malaysia Veterinary Biomarkers Market
7.3.5.6.1 Malaysia Veterinary Biomarkers Market by Animal Type
7.3.5.6.2 Malaysia Veterinary Biomarkers Market by Disease Type
7.3.5.6.3 Malaysia Veterinary Biomarkers Market by Product Type
7.3.5.6.4 Malaysia Veterinary Biomarkers Market by Application
7.3.5.7 Rest of Asia Pacific Veterinary Biomarkers Market
7.3.5.7.1 Rest of Asia Pacific Veterinary Biomarkers Market by Animal Type
7.3.5.7.2 Rest of Asia Pacific Veterinary Biomarkers Market by Disease Type
7.3.5.7.3 Rest of Asia Pacific Veterinary Biomarkers Market by Product Type
7.3.5.7.4 Rest of Asia Pacific Veterinary Biomarkers Market by Application
7.4 LAMEA Veterinary Biomarkers Market
7.4.1 LAMEA Veterinary Biomarkers Market by Animal Type
7.4.1.1 LAMEA Companion Market by Country
7.4.1.2 LAMEA Veterinary Biomarkers Market by Companion Animal Type
7.4.1.2.1 LAMEA Dogs Market by Country
7.4.1.2.2 LAMEA Cats Market by Country
7.4.1.2.3 LAMEA Others Market by Country
7.4.1.3 LAMEA Production Market by Country
7.4.2 LAMEA Veterinary Biomarkers Market by Disease Type
7.4.2.1 LAMEA Inflammatory & Infectious Diseases Market by Country
7.4.2.2 LAMEA Turf & Landscaping Market by Country
7.4.2.3 LAMEA Tumor Market by Country
7.4.2.4 LAMEA Skeletal Muscle Diseases Market by Country
7.4.2.5 LAMEA Others Market by Country
7.4.3 LAMEA Veterinary Biomarkers Market by Product Type
7.4.3.1 LAMEA Biomarkers, Kits & Reagents Market by Country
7.4.3.2 LAMEA Biomarker Readers Market by Country
7.4.4 LAMEA Veterinary Biomarkers Market by Application
7.4.4.1 LAMEA Disease Diagnostics Market by Country
7.4.4.2 LAMEA Preclinical Research Market by Country
7.4.4.3 LAMEA Others Market by Country
7.4.5 LAMEA Veterinary Biomarkers Market by Country
7.4.5.1 Brazil Veterinary Biomarkers Market
7.4.5.1.1 Brazil Veterinary Biomarkers Market by Animal Type
7.4.5.1.2 Brazil Veterinary Biomarkers Market by Disease Type
7.4.5.1.3 Brazil Veterinary Biomarkers Market by Product Type
7.4.5.1.4 Brazil Veterinary Biomarkers Market by Application
7.4.5.2 Argentina Veterinary Biomarkers Market
7.4.5.2.1 Argentina Veterinary Biomarkers Market by Animal Type
7.4.5.2.2 Argentina Veterinary Biomarkers Market by Disease Type
7.4.5.2.3 Argentina Veterinary Biomarkers Market by Product Type
7.4.5.2.4 Argentina Veterinary Biomarkers Market by Application
7.4.5.3 UAE Veterinary Biomarkers Market
7.4.5.3.1 UAE Veterinary Biomarkers Market by Animal Type
7.4.5.3.2 UAE Veterinary Biomarkers Market by Disease Type
7.4.5.3.3 UAE Veterinary Biomarkers Market by Product Type
7.4.5.3.4 UAE Veterinary Biomarkers Market by Application
7.4.5.4 Saudi Arabia Veterinary Biomarkers Market
7.4.5.4.1 Saudi Arabia Veterinary Biomarkers Market by Animal Type
7.4.5.4.2 Saudi Arabia Veterinary Biomarkers Market by Disease Type
7.4.5.4.3 Saudi Arabia Veterinary Biomarkers Market by Product Type
7.4.5.4.4 Saudi Arabia Veterinary Biomarkers Market by Application
7.4.5.5 South Africa Veterinary Biomarkers Market
7.4.5.5.1 South Africa Veterinary Biomarkers Market by Animal Type
7.4.5.5.2 South Africa Veterinary Biomarkers Market by Disease Type
7.4.5.5.3 South Africa Veterinary Biomarkers Market by Product Type
7.4.5.5.4 South Africa Veterinary Biomarkers Market by Application
7.4.5.6 Nigeria Veterinary Biomarkers Market
7.4.5.6.1 Nigeria Veterinary Biomarkers Market by Animal Type
7.4.5.6.2 Nigeria Veterinary Biomarkers Market by Disease Type
7.4.5.6.3 Nigeria Veterinary Biomarkers Market by Product Type
7.4.5.6.4 Nigeria Veterinary Biomarkers Market by Application
7.4.5.7 Rest of LAMEA Veterinary Biomarkers Market
7.4.5.7.1 Rest of LAMEA Veterinary Biomarkers Market by Animal Type
7.4.5.7.2 Rest of LAMEA Veterinary Biomarkers Market by Disease Type
7.4.5.7.3 Rest of LAMEA Veterinary Biomarkers Market by Product Type
7.4.5.7.4 Rest of LAMEA Veterinary Biomarkers Market by Application
Chapter 8. Company Profiles
8.1 Zoetis, Inc.
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Regional Analysis
8.1.3 Research & Development Expense
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.1.4.2 Acquisition and Mergers:
8.2 Merck & Co., Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.3 Virbac
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 IDEXX Laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 MI:RNA Diagnostics Ltd.
8.5.1 Company Overview
8.6 Mercodia AB
8.6.1 Company Overview
8.7 Antech Diagnostics, Inc. (Mars, Inc.)
8.7.1 Company Overview
8.8 Avacta Animal Health Limited (Vimian Group)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.9 Life Diagnostics, Inc.
8.9.1 Company Overview
8.10. Acuvet Biotech
8.10.1 Company Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings